Progesterone for Subchorionic Hematoma
Progesterone supplementation is not specifically indicated for subchorionic hematoma based on current evidence-based guidelines, as the major society recommendations focus on preterm birth prevention rather than hematoma treatment. 1
Current Guideline-Based Recommendations
The American College of Obstetricians and Gynecologists does not recommend progesterone for subchorionic hematoma as a primary indication. 1 The established progesterone indications are:
- Prior spontaneous preterm birth: 17-hydroxyprogesterone caproate (17P) 250 mg IM weekly from 16-20 weeks until 36 weeks 1
- Short cervical length (≤20 mm) without prior preterm birth: Vaginal progesterone 90-mg gel or 200-mg suppository daily from diagnosis until 36 weeks 1
- No evidence supports progesterone use for routine pregnancy without these specific risk factors 1
Off-Label Consideration Based on Limited Evidence
Despite lack of guideline support, the American College of Obstetricians and Gynecologists suggests that oral progesterone 400 mg daily may be considered for early pregnancy bleeding with subchorionic hemorrhage, though the evidence is less robust than for vaginal administration. 2 If this approach is chosen:
- Vaginal micronized progesterone 400 mg twice daily (total 800 mg/day) is an alternative option for women with early pregnancy bleeding and history of previous miscarriage(s) 3
- Continue therapy typically until 34-37 weeks of gestation 2
- Important caveat: This dosing differs substantially from preterm birth prevention protocols and should not be confused with 17P formulations 3
Research Evidence (Not Guideline-Supported)
Small studies suggest potential benefit, but these do not constitute guideline-level evidence:
- One RCT (n=62) showed vaginal progesterone 400 mg improved hematoma resorption compared to no treatment, though alpha lipoic acid performed better 4
- Oral dydrogesterone 40 mg/day reduced abortion rate to 7% versus 18.7% with micronized progesterone in one observational study (n=100) 5
- Combination therapy with progesterone plus supplements showed faster hematoma resolution in pilot studies 6, 7
These research findings are preliminary and have not been incorporated into major society guidelines. 1
Critical Clinical Caveats
- Peanut allergy is an absolute contraindication to progesterone capsules containing peanut oil 8
- Progesterone may cause transient dizziness, drowsiness, and blurred vision; advise taking at bedtime in standing position with water 8
- Do not use progesterone for multiple gestations, active preterm labor, or preterm premature rupture of membranes—no evidence of benefit 1, 3
- Injectable 17P should never be substituted for oral or vaginal progesterone; these are distinct formulations with different indications 3, 9
Practical Algorithm
If the patient has subchorionic hematoma alone (no prior preterm birth, normal cervical length):
- Standard obstetric care is recommended per guidelines 1
- Off-label progesterone may be considered if there is concurrent early pregnancy bleeding and history of miscarriage, using vaginal progesterone 400 mg twice daily 3
If the patient has subchorionic hematoma PLUS prior spontaneous preterm birth:
- Start 17P 250 mg IM weekly at 16-20 weeks (this is for preterm birth prevention, not hematoma treatment) 1
If the patient develops short cervix (≤20 mm) at or before 24 weeks:
- Add vaginal progesterone 90-mg gel or 200-mg suppository daily regardless of hematoma status 1
Monitoring Considerations
- Serial ultrasound to assess hematoma size and pregnancy viability 4, 7
- Most miscarriages with subchorionic hematoma occur in the first trimester; passing this stage often leads to successful delivery 10
- Subchorionic hematoma significantly increases miscarriage/stillbirth risk compared to pregnancies without hematoma 10